Global Molecular Diagnostics Market Research Report – Segmented By Product (Reagents and Kits, Instruments and Software &Services); By Technology (Polymerase Chain Reactions (PCR), Hybridization, DNA Sequencing, Microarray, and Others); Application (Infectious Diseases Diagnostics, Oncology, Genetic Testing, and Others); By End Users (Hospitals, Laboratories and Others); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)

Chapter 1. Molecular Diagnostics Market – Scope & Methodology
1.1    Market Segmentation
1.2    Scope, Assumptions & Limitations
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources 
Chapter 2. Molecular Diagnostics Market – Executive Summary
2.1    Market Size & Forecast – (2022 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
              2.2.1    Demand Side
              2.2.2    Supply Side
2.3    Attractive Investment Propositions
2.4    COVID-19 Impact Analysis 
Chapter 3. Molecular Diagnostics Market – Competition Scenario
3.1    Market Share Analysis & Company Benchmarking
3.2    Competitive Strategy & Development Scenario
3.3    Competitive Pricing Analysis
3.4    Supplier-Distributor Analysis
Chapter 4. Molecular Diagnostics Market Entry Scenario
4.1    Regulatory Scenario
4.2    Case Studies – Key Start-ups
4.3    Customer Analysis
4.4    PESTLE Analysis
4.5    Porters Five Force Model
              4.5.1    Bargaining Power of Suppliers
              4.5.2    Bargaining Powers of Customers
              4.5.3    Threat of New Entrants
              4.5.4    Rivalry among Existing Players
              4.5.5    Threat of Substitutes 
Chapter 5. Molecular Diagnostics Market – Landscape
5.1    Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities 
Chapter 6. Molecular Diagnostics Market – By Product
6.1    Introduction/Key Findings   
6.2    Reagents and Kits
6.3    Instruments
6.4    Software &Services
6.5    Y-O-Y Growth trend Analysis By Product
6.6    Absolute $ Opportunity Analysis By Product, 2023-2030 
Chapter 7. Molecular Diagnostics Market – By Technology
7.1    Introduction/Key Findings   
7.2    Polymerase Chain Reactions (PCR)
7.3    Hybridization
7.4    DNA Sequencing
7.5    Microarray
7.6    Isothermal Nucleic Acid Amplification Technology (INAAT)
7.7    Others
7.8    Y-O-Y Growth  trend Analysis By Technology
7.9    Absolute $ Opportunity Analysis By Technology, 2023-2030 
Chapter 8. Molecular Diagnostics Market – By Application
8.1    Introduction/Key Findings   
8.2    Infectious Diseases Diagnostics
8.3    Oncology
8.4    Genetic Testing
8.5    Blood Screening
8.6    Others
8.7    Y-O-Y Growth trend Analysis By Application
8.8    Absolute $ Opportunity Analysis By Application, 2023-2030
Chapter 9. Molecular Diagnostics Market – By End Users
9.1    Introduction/Key Findings   
9.2    Hospitals
9.3    Laboratories
9.4    Others
9.5    Y-O-Y Growth trend Analysis By End Users
9.6    Absolute $ Opportunity Analysis By End Users, 2023-2030 
Chapter 10. Molecular Diagnostics Market, By Geography – Market Size, Forecast, Trends & Insights
10.1    North America
              10.1.1    By Country
                            10.1.1.1    U.S.A.
                            10.1.1.2    Canada
                            10.1.1.3    Mexico
              10.1.2    By Product
                            10.1.2.1    By Technology
              10.1.3    By Application
              10.1.4    Countries & Segments - Market Attractiveness Analysis
10.2    Europe
              10.2.1    By Country
                            10.2.1.1    U.K
                            10.2.1.2    Germany
                            10.2.1.3    France
                            10.2.1.4    Italy
                            10.2.1.5    Spain
                            10.2.1.6    Rest of Europe
              10.2.2    By Product
              10.2.3    By Technology
              10.2.4    By Application
              10.2.5    By By End Users
              10.2.6    Countries & Segments - Market Attractiveness Analysis
10.3    Asia Pacific
              10.3.1    By Country
                            10.3.1.1    China
                            10.3.1.2    Japan
                            10.3.1.3    South Korea
                            10.3.1.4    India      
                            10.3.1.5    Australia & New Zealand
                            10.3.1.6    Rest of Asia-Pacific
              10.3.2    By Product
              10.3.3    By Technology
              10.3.4    By Application
              10.3.5    By By End Users
              10.3.6    Countries & Segments - Market Attractiveness Analysis
10.4    South America
              10.4.1    By Country
                            10.4.1.1    Brazil
                            10.4.1.2    Argentina
                            10.4.1.3    Colombia
                            10.4.1.4    Chile
                            10.4.1.5    Rest of South America
              10.4.2    By Product
              10.4.3    By Technology
              10.4.4    By Application
              10.4.5    By By End Users
              10.4.6    Countries & Segments - Market Attractiveness Analysis
10.5    Middle East & Africa
              10.5.1    By Country
                            10.5.1.1    United Arab Emirates (UAE)
                            10.5.1.2    Saudi Arabia
                            10.5.1.3    Qatar
                            10.5.1.4    Israel
                            10.5.1.5    South Africa
                            10.5.1.6    Nigeria
                            10.5.1.7    Kenya
                            10.5.1.8    Egypt
                            10.5.1.9    Rest of MEA
              10.5.2    By Product
              10.5.3    By Technology
              10.5.4    By Application
              10.5.5    By By End Users
              10.5.6    Countries & Segments - Market Attractiveness Analysis 
Chapter 11. Molecular Diagnostics Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
11.1    Roche Diagnostics
11.2    Qiagen
11.3    Thermo Fisher Scientific
11.4    Abbott Laboratories
11.5    Bio-Rad Laboratories
11.6    Hologic, Inc.
11.7    Danaher Corporation
11.8    Siemens Healthineers
11.9    Agilent Technologies
11.10    Grifols
11.11    Myriad Genetics


 

Download Sample

The field with (*) is required.

Choose License Type

$

2850

$

5250

$

4500

$

1800

Frequently Asked Questions

 The Global Molecular Diagnostics Market was valued at USD 11.6 billion in 2022 and is projected to reach a market size of USD 22.5 billion by the end of 2030, indicating a substantial CAGR of 8.633% during the forecast period of 2023-2030.

Advancements in technology, the rising prevalence of chronic diseases, personalized medicine and targeted therapies, and government initiatives and funding are key drivers.

 The market is segmented into polymerase chain reaction, next-generation sequencing, microarrays, isothermal nucleic acid amplification technology, and others.

North America dominates the Global Molecular Diagnostics Market.

Roche Diagnostics, Qiagen, Thermo Fisher Scientific, Abbott Laboratories, Bio-Rad Laboratories, Hologic, Inc., Danaher Corporation, Siemens Healthineers, Agilent Technologies, Grifols, and Myriad Genetics are among the key players in the market.